Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"We are honored to be recognized as the highest leader in CTMS by Everest Group," said Tom Doyle, chief technology officer, Medidata. "This accolade underscores our unwavering commitment to transforming research and reaffirms our strategy to deliver new, AI-powered experiences that reshape how organizations design, plan, and manage trials end-to-end with the greatest impact."
Added Doyle, "In 2025, Medidata will embed AI-driven insights within study planning and execution solutions, enabling simulation of trial design, process simplification, and enhanced efficiency."
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
NEW YORK -- Businesswire -- Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata&index=1&md5=13f9038490d8f84d03716dc2a6fafaac), a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a leader in Everest Group's first-ever Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment 2024. The report assessed 13 providers based on the market impact of their products and their ability to deliver successful, high-quality offerings.
Medidata Rave CTMS (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fclinical-trial-products%2Fclinical-operations%2Fctms%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata+Rave+CTMS&index=2&md5=3878e8a580080d1661a517184b950b9f) leads the industry by providing seamless, real-time patient data outputs that transform enrollment tracking and enable faster, data-driven decisions. Offering instant visibility for study teams, Rave CTMS streamlines collaboration, eliminates manual data entry, and accelerates trial timelines with exceptional accuracy.
“We are honored to be recognized as the highest leader in CTMS by Everest Group,” said Tom Doyle, chief technology officer, Medidata. “This accolade underscores our unwavering commitment to transforming research and reaffirms our strategy to deliver new, AI-powered experiences that reshape how organizations design, plan, and manage trials end-to-end with the greatest impact.”
Added Doyle, “In 2025, Medidata will embed AI-driven insights within study planning and execution solutions, enabling simulation of trial design, process simplification, and enhanced efficiency.”
Medidata is the only provider to be named a leader in Everest Group’s CTMS, electronic data capture (EDC) and decentralized clinical trial (DCT) assessments for its Medidata Rave EDC (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fabout-us%2Fnews-and-press%2Fmedidata-recognized-as-a-leader-in-everest-groups-inaugural-electronic-data-capture-peak-matrix-assessment%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata+Rave+EDC&index=3&md5=ce118097125ff8f3bc84ff8373ea1f96), Medidata Platform (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fclinical-trial-products%2Funified-platform%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata+Platform&index=4&md5=6682f27c5e061121dc93c271a12ff866), and its work in DCT (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fabout-us%2Fnews-and-press%2Fmedidata-secures-top-honors-in-everest-groups-decentralized-clinical-trial-platforms-peak-matrix-assessment%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=DCT&index=5&md5=86530fd3b22640171998a5c07dc5efb8).
For more information, visit our website (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww2.everestgrp.com%2Freportaction%2FEGR-2024-72-R-6771%2FMarketing&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=website&index=6&md5=4995d9c6ad1457a4e92ec2c8101800cf).
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all - consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.
About Everest Group
Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group’s PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth content at www.everestgrp.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241112190210/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Medidata
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 현대차그룹, 2024년 대표이사·사장단 임원인사 - 뉴스와이어
- 가을밤, 한국의집 궁중다과와 고려시대 최고급 탁주에 취하다 - 뉴스와이어
- 좋은땅출판사 ‘비전공자도 이해하며 경험할 수 있는 AI 왕국’ 출간 - 뉴스와이어
- 헬리녹스, 창립 15주년 기념 100% 스케일 베어브릭 컬렉션 출시 - 뉴스와이어
- 최윤정 소리북 독주회 ‘나는 고수다 Ⅱ’ 완북 동초제 적벽가 강릉서 개최 - 뉴스와이어
- 몰렉스, SAP 솔루션으로 지능형 공급망 협업 추진 - 뉴스와이어
- 삼성전자, 10조원 규모 자사주 매입 결정 - 뉴스와이어
- HD현대중공업, 캐나다서 최적의 잠수함 솔루션 제안 - 뉴스와이어
- 서울시립청소년음악센터, 제1회 서울청소년댄스페스티벌 성료 - 뉴스와이어
- 쿠팡과 함께하는 더 풍성해진 ‘유럽연합 푸드 위크’ - 뉴스와이어